Working... Menu

Leader - Evaluation of Endotak Reliance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00180349
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 14, 2017
Information provided by (Responsible Party):
Boston Scientific Corporation

Brief Summary:
The objective of this study is to demonstrate the efficacy of the ENDOTAK® RELIANCE™ defibrillation leads connected to a defibrillator or a cardiac resynchronization defibrillator from implant until 12 months.

Condition or disease Intervention/treatment
Ventricular Tachycardia Ventricular Fibrillation Device: Endotak Reliance

Detailed Description:
Baseline and clinical data were collected at inclusion, as were data on procedural characteristics, device implantation-related adverse events and device programming at the time of hospital discharge. Patients were subsequently divided in two groups: patients who underwent VF induction at implantation or before hospital discharge(VF induction group); and patients who did not undergo VF induction (untested group).The patients were followed up at 3—6 months and at12 months after the implantation. VF induction procedures were left to the investigator's discretion, but reasons for not performing a VF induction at implantation were recorded prospectively. ICD programming parameters for tachycardia or bradycardia were also left at the investigator's discretion.

Layout table for study information
Study Type : Observational
Actual Enrollment : 904 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Short and Long Term Evaluation of Electrical Measurements and Defibrillation Energies, Results of ATP and Diagnostic Functions of Devices Connected to Endotak RELIANCE® Defibrillation Leads
Study Start Date : December 2004
Actual Primary Completion Date : July 2009
Actual Study Completion Date : July 2009

Intervention Details:
  • Device: Endotak Reliance
    Endotak Reliance is a defibrillation lead delivering pacing and defibrillation therapy to the ventricle as needed.

Primary Outcome Measures :
  1. Defibrillation testing (DT) procedures and consequences on clinical outcomes [ Time Frame: at implant ]
    to determine the DT procedures used in everyday practice, to compare the characteristics of patients with or without DTand to compare severe adverse events in these two populations during implantation

  2. Defibrillation testing (DT) procedures and consequences on clinical outcomes [ Time Frame: during 1 year follow-up ]
    to determine the DT procedures used in everyday practice, to compare the characteristics of patients with or without DTand to compare severe adverse events in these two populations during 1 year follow-up

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Consecutive patients with the indication for an implantable ICD are invited to participate.

Inclusion Criteria:

  • ICD indication according to current guidelines with or without cardiac resynchronization therapy, being implanted with a Guidant ENDOTAK RELIANCE defibrillation lead as first implant, age above 18 years, able to understand the nature of the study and to be available for all follow-ups, having given consent in writing for anonymous data collection, life expectancy > 1 year.

Exclusion Criteria:

  • device replacement without concomitant implant of a Reliance defibrillation lead, pregnancy or of birth bearing age without contraception, participation in another clinical study, short life expectancy due to other medical conditions, not willing to sign the consent form, geographically unstable for a defibrillator follow-up as required per protocol, having a ventricular arrhythmia, that can be treated by drugs or surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00180349

Layout table for location information
CH Amiens
Amiens, France, 80054
CHU Angers
Angers, France, 49033
Hôpital Angoulème
Angoulème, France, 16470
Clinique Cardiologique Aressy
Aressy, France, 64320
CH Avignon
Avignon, France, 84902
CHU du Morvan
Brest, France, 29609
Hôpital Côte de Nacre
Caen, France, 14033
CHU Henri Mondor
Créteil, France, 94000
CHU Michalon
Grenoble, France, 38043
CH Hôpital Nord
Marseille, France, 13008
CHU La Timone
Marseille, France, 13385
CHU Montpellier
Montpellier, France, 34295
CHU Brabois
Nancy, France
Nouvelle Clinique Nantaise
Nantes, France, 44000
CHU Nantes
Nantes, France, 44295
CHU Nice
Nice, France, 06002
CHU D'Orleans
Orleans, France, 45000
Clinique Bizet
Paris, France
Pau, France, 64046
CHU Pontchaillou
Rennes, France, 35033
CHU Rouen
Rouen, France, 76031
Centre cardiologique du Nord
St. Denis, France, 93000
CMC Arnaud Tzanck
St. Laurent du Var, France, 6700
CHU Rangueil
Toulouse, France, 31403
Clinique St. Gatien
Tours, France, 37000
Sponsors and Collaborators
Boston Scientific Corporation
Layout table for investigator information
Principal Investigator: Nicolas Sadoul, MD CHU Brabois, Nancy
Principal Investigator: Arnaud Lazarus, MD Clinique Bizet, Paris

Layout table for additonal information
Responsible Party: Boston Scientific Corporation Identifier: NCT00180349     History of Changes
Other Study ID Numbers: Leader v. 1.0 10/04
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: April 14, 2017
Last Verified: April 2017

Additional relevant MeSH terms:
Layout table for MeSH terms
Tachycardia, Ventricular
Ventricular Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease
Pathologic Processes